Клиническое наблюдение IgG4-ассоциированной болезни у пациента с лимфомой Беркитта

1. Deshpande V. Consensus statement on the pathology of IgG4-related disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2012;25(9):1181-92. doi: 10.1038/modpathol.2012.72
2. Kamisawa T. IgG4-related disease. Lancet. 2015 Apr 11;385(9976):1460-71. doi: 10.1016/S0140-6736(14)60720-0
3. Буеверов А.О., Кучерявый Ю.А. IgG4-ассоциированная болезнь: монография. М.: Форте Принт, 2014:128 с. [Bueverov AO, Kucheryavy YuA. IgG4-associated disease. Moscow: Forte Print, 2014:128 p. (In Russ.)].
4. Okazaki R, Ikeura T, Takaoka M. Сurrent concept and diagnosis IgG4-related disease in the hepato-bili-pancreatic system. J Gastroenterol. 2013;48(3):303-14. doi: 10.1007/s00535-012-0744-3
5. Lecler A, Zmuda M, Deschamps R. Infraorbital Nerve Involvement on Magnetic Resonance Imaging in Igg4-Related Ophthalmic Disease: A Highly Suggestive Sign. Ophthalmology. 2018 Apr;125(4):577. doi: 10.1016/j.ophtha. 2017.12.025
6. Spapen J, Reekmans A, Berghmans B. IgG4-related disease of the hepatobiliary tract: 2 case reports and review of the literature. Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):83-7.
7. Sato Y. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2009;22(4):589-99. doi: 10.1038/modpathol.2009.17
8. Carruthers MN. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Annals of the rheumatic diseases. 2015;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
9. Hart PA, Smyrk TC, Chari ST. Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2015;28(2):238-47. doi: 10.1038/modpathol.2014.91
10. Wallace ZS. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Annals of the rheumatic diseases. 2015;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
11. Губергриц Н.Б., Дядык Е.А., Клочков А.Е., Беляева Н.В., Иванова М.Д., Гинкота Е.А., Чирков Ю.Э. Клиническое наблюдение IgG4-ассоциированной болезни. Вестник клуба панкреатологов. 2018;38(1):34-41 [Gubergrits NB, Dyadyk EA, Klochkov AE Belyaeva NV, Ivanova MD, Ginkota EA, Chirkov YuE. Clinical observation of IgG4-associated disease. Bulletin of the club of pancreatologists. 2018;38(1):34-41 (In Russ.)].
12. Ditea Petr, Nechutovab Hana. Autoimmune pancreatitis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Mar;158(1):17-22. doi: 10.5507/bp.2013.094
13. Mitsuaki Ihsida. Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma. Intern J Clinical and Experimental Pathology (IJCEP). 2013;6 (11):2560-8.
14. Li J, Ma JM, Ge X. Role of IgG4 serology in identifying common orbital lymphoproliferative disorders. Int J Ophthalmol. 2016;9(2):275-7. doi: 10.18240/ijo.2016.02.18
15. Kim HM, Moon Jar Chung, Jae Bock Chung. Remission and relapse of autoimmune pancreatitis. Focusing on corticosteroid treatment. Pancreas. 2010;39(5):555-60.
16. Wang L, Zhang P, Wang M, Feng R Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
17. Khosroshahi A. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis & rheumatology. 2015;67(7):1688-99. doi: 10.1002/art.39132
18. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Current opinion in rheumatology. 2011;23(1):67-71. doi: 10.1097/BOR.0b013e328341a240
19. Hart PA, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607-15. doi: 10.1136/gutjnl-2012-302886
20. Седышев С.Х., Васильев В.И., Ковригина А.М. и др. Заболевание, связанное с IgG4: характеристика группы больных и терапия ритуксимабом. Терапевтический архив. 2013;85(2):48-53 [Sedyshev SKh, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease: patient group characterization and rituximab therapy. Therapeutic Archive. 2013;85(2):48-53 (In Russ.)].
21. Барях Е.А., Тюрина Н.Г., Воробьев В.И. и др. Двенадцатилетний опыт терапии лимфомы Беркитта по протоколу ЛБ-М-04. Терапевтический архив. 2015;87(7):4-11 [Baryakh EA, Тyurina NG, Vorobyev VI, et al. Therapy for Burkitt’s lymphoma according to the BL-M-04 protocol: 12-year experience. Therapeutic Archive. 2015;87(7):4-11 (In Russ.)]. doi: 10.17116/terarkh20158774-14
22. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-7. doi: 10.1136/gut.2008.172908
23. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M, Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471-7. doi: 10.1007/s00535-010-0221-9
24. Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961-70. doi: 10.1007/s00535-014-0945-z

________________________________________________

1. Deshpande V. Consensus statement on the pathology of IgG4-related disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2012;25(9):1181-92. doi: 10.1038/modpathol.2012.72
2. Kamisawa T. IgG4-related disease. Lancet. 2015 Apr 11;385(9976):1460-71. doi: 10.1016/S0140-6736(14)60720-0
3. [Bueverov AO, Kucheryavy YuA. IgG4-associated disease. Moscow: Forte Print, 2014:128 p. (In Russ.)].
4. Okazaki R, Ikeura T, Takaoka M. Сurrent concept and diagnosis IgG4-related disease in the hepato-bili-pancreatic system. J Gastroenterol. 2013;48(3):303-14. doi: 10.1007/s00535-012-0744-3
5. Lecler A, Zmuda M, Deschamps R. Infraorbital Nerve Involvement on Magnetic Resonance Imaging in Igg4-Related Ophthalmic Disease: A Highly Suggestive Sign. Ophthalmology. 2018 Apr;125(4):577. doi: 10.1016/j.ophtha. 2017.12.025
6. Spapen J, Reekmans A, Berghmans B. IgG4-related disease of the hepatobiliary tract: 2 case reports and review of the literature. Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):83-7.
7. Sato Y. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2009;22(4):589-99. doi: 10.1038/modpathol.2009.17
8. Carruthers MN. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Annals of the rheumatic diseases. 2015;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
9. Hart PA, Smyrk TC, Chari ST. Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4. Modern pathology: an official journal of the United States and Canadian Academy of Pathology Inc. 2015;28(2):238-47. doi: 10.1038/modpathol.2014.91
10. Wallace ZS. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Annals of the rheumatic diseases. 2015;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
11.[Gubergrits NB, Dyadyk EA, Klochkov AE Belyaeva NV, Ivanova MD, Ginkota EA, Chirkov YuE. Clinical observation of IgG4-associated disease. Bulletin of the club of pancreatologists. 2018;38(1):34-41 (In Russ.)].
12. Ditea Petr, Nechutovab Hana. Autoimmune pancreatitis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Mar;158(1):17-22. doi: 10.5507/bp.2013.094
13. Mitsuaki Ihsida. Occurrence of anaplastic large cell lymphoma following IgG4-related autoimmune pancreatitis and cholecystitis and diffuse large B-cell lymphoma. Intern J Clinical and Experimental Pathology (IJCEP). 2013;6 (11):2560-8.
14. Li J, Ma JM, Ge X. Role of IgG4 serology in identifying common orbital lymphoproliferative disorders. Int J Ophthalmol. 2016;9(2):275-7. doi: 10.18240/ijo.2016.02.18
15. Kim HM, Moon Jar Chung, Jae Bock Chung. Remission and relapse of autoimmune pancreatitis. Focusing on corticosteroid treatment. Pancreas. 2010;39(5):555-60.
16. Wang L, Zhang P, Wang M, Feng R Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
17. Khosroshahi A. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis & rheumatology. 2015;67(7):1688-99. doi: 10.1002/art.39132
18. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Current opinion in rheumatology. 2011;23(1):67-71. doi: 10.1097/BOR.0b013e328341a240
19. Hart PA, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut. 2013;62(11):1607-15. doi: 10.1136/gutjnl-2012-302886
20.[Sedyshev SKh, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease: patient group characterization and rituximab therapy. Therapeutic Archive. 2013;85(2):48-53 (In Russ.)].
21.[Baryakh EA, Тyurina NG, Vorobyev VI, et al. Therapy for Burkitt’s lymphoma according to the BL-M-04 protocol: 12-year experience. Therapeutic Archive. 2015;87(7):4-11 (In Russ.)]. doi: 10.17116/terarkh20158774-14
22. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut. 2009;58:1504-7. doi: 10.1136/gut.2008.172908
23. Kamisawa T, Okazaki K, Kawa S, Shimosegawa T, Tanaka M, Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society. Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol. 2010;45:471-7. doi: 10.1007/s00535-010-0221-9
24. Kamisawa T, Okazaki K, Kawa S, et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014;49:961-70. doi: 10.1007/s00535-014-0945-z

Т.И. Фейдорова, Л.В. Винокурова, С.Ю. Двойников, О.М. Михеева, Г.А. Дудина, А.О. Акопова 

ГБУЗ «Московский клинический научно-практический центр им. А.С. Логинова» Департамента здравоохранения г. Москвы, Москва, Россия

________________________________________________

T.I. Feydorova, L.V. Vinokurova, S.Yu. Dvoynikov, O.M. Mikheeva, G.A. Dudin, A.O. Akopova

Loginov Moscow Clinical Scientific and Practical Center, Moscow, Russia